Non-steroidal Anti-inflammatory Drugs Market by Route of Administration (Oral, Parenteral, Topical), Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2025-2033

Non-steroidal Anti-inflammatory Drugs Market by Route of Administration (Oral, Parenteral, Topical), Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6941

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global Non-steroidal Anti-inflammatory Drugs Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Global Non-steroidal Anti-inflammatory Drugs Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Global Non-steroidal Anti-inflammatory Drugs Market - Breakup by Route of Administration
6.1 Oral

6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2025-2033)
6.2 Parenteral
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2025-2033)
6.3 Topical
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2019-2024)
6.3.3 Market Segmentation
6.3.4 Market Forecast (2025-2033)
6.4 Attractive Investment Proposition by Route of Administration

7 Global Non-steroidal Anti-inflammatory Drugs Market - Breakup by Disease Indication
7.1 Arthritis
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2025-2033)
7.2 Migraine
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2025-2033)
7.3 Ophthalmic Diseases
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2019-2024)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2025-2033)
7.4 Others
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2019-2024)
7.4.3 Market Forecast (2025-2033)
7.5 Attractive Investment Proposition by Disease Indication

8 Global Non-steroidal Anti-inflammatory Drugs Market - Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2025-2033)
8.2 Retail Pharmacy
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2025-2033)
8.3 Online Pharmacy
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2019-2024)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2025-2033)
8.4 Attractive Investment Proposition by Distribution Channel

9 Global Non-steroidal Anti-inflammatory Drugs Market – Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Drivers
9.1.1.2 Historical and Current Market Trends (2019-2024)
9.1.1.3 Market Breakup by Route of Administration
9.1.1.4 Market Breakup by Disease Indication
9.1.1.5 Market Breakup by Distribution Channel
9.1.1.6 Key Players
9.1.1.7 Market Forecast (2025-2033)
9.1.2 Canada
9.1.2.1 Market Drivers
9.1.2.2 Historical and Current Market Trends (2019-2024)
9.1.2.3 Market Breakup by Route of Administration
9.1.2.4 Market Breakup by Disease Indication
9.1.2.5 Market Breakup by Distribution Channel
9.1.2.6 Key Players
9.1.2.7 Market Forecast (2025-2033)
9.2 Europe
9.2.1 Germany
9.2.1.1 Market Drivers
9.2.1.2 Historical and Current Market Trends (2019-2024)
9.2.1.3 Market Breakup by Route of Administration
9.2.1.4 Market Breakup by Disease Indication
9.2.1.5 Market Breakup by Distribution Channel
9.2.1.6 Key Players
9.2.1.7 Market Forecast (2025-2033)
9.2.2 France
9.2.2.1 Market Drivers
9.2.2.2 Historical and Current Market Trends (2019-2024)
9.2.2.3 Market Breakup by Route of Administration
9.2.2.4 Market Breakup by Disease Indication
9.2.2.5 Market Breakup by Distribution Channel
9.2.2.6 Key Players
9.2.2.7 Market Forecast (2025-2033)
9.2.3 United Kingdom
9.2.3.1 Market Drivers
9.2.3.2 Historical and Current Market Trends (2019-2024)
9.2.3.3 Market Breakup by Route of Administration
9.2.3.4 Market Breakup by Disease Indication
9.2.3.5 Market Breakup by Distribution Channel
9.2.3.6 Key Players
9.2.3.7 Market Forecast (2025-2033)
9.2.4 Italy
9.2.4.1 Market Drivers
9.2.4.2 Historical and Current Market Trends (2019-2024)
9.2.4.3 Market Breakup by Route of Administration
9.2.4.4 Market Breakup by Disease Indication
9.2.4.5 Market Breakup by Distribution Channel
9.2.4.6 Key Players
9.2.4.7 Market Forecast (2025-2033)
9.2.5 Spain
9.2.5.1 Market Drivers
9.2.5.2 Historical and Current Market Trends (2019-2024)
9.2.5.3 Market Breakup by Route of Administration
9.2.5.4 Market Breakup by Disease Indication
9.2.5.5 Market Breakup by Distribution Channel
9.2.5.6 Key Players
9.2.5.7 Market Forecast (2025-2033)
9.2.6 Others
9.2.6.1 Historical and Current Market Trends (2019-2024)
9.2.6.2 Market Forecast (2025-2033)
9.3 Asia Pacific
9.3.1 China
9.3.1.1 Market Drivers
9.3.1.2 Historical and Current Market Trends (2019-2024)
9.3.1.3 Market Breakup by Route of Administration
9.3.1.4 Market Breakup by Disease Indication
9.3.1.5 Market Breakup by Distribution Channel
9.3.1.6 Key Players
9.3.1.7 Market Forecast (2025-2033)
9.3.2 Japan
9.3.2.1 Market Drivers
9.3.2.2 Historical and Current Market Trends (2019-2024)
9.3.2.3 Market Breakup by Route of Administration
9.3.2.4 Market Breakup by Disease Indication
9.3.2.5 Market Breakup by Distribution Channel
9.3.2.6 Key Players
9.3.2.7 Market Forecast (2025-2033)
9.3.3 India
9.3.3.1 Market Drivers
9.3.3.2 Historical and Current Market Trends (2019-2024)
9.3.3.3 Market Breakup by Route of Administration
9.3.3.4 Market Breakup by Disease Indication
9.3.3.5 Market Breakup by Distribution Channel
9.3.3.6 Key Players
9.3.3.7 Market Forecast (2025-2033)
9.3.4 South Korea
9.3.4.1 Market Drivers
9.3.4.2 Historical and Current Market Trends (2019-2024)
9.3.4.3 Market Breakup by Route of Administration
9.3.4.4 Market Breakup by Disease Indication
9.3.4.5 Market Breakup by Distribution Channel
9.3.4.6 Key Players
9.3.4.7 Market Forecast (2025-2033)
9.3.5 Australia
9.3.5.1 Market Drivers
9.3.5.2 Historical and Current Market Trends (2019-2024)
9.3.5.3 Market Breakup by Route of Administration
9.3.5.4 Market Breakup by Disease Indication
9.3.5.5 Market Breakup by Distribution Channel
9.3.5.6 Key Players
9.3.5.7 Market Forecast (2025-2033)
9.3.6 Indonesia
9.3.6.1 Market Drivers
9.3.6.2 Historical and Current Market Trends (2019-2024)
9.3.6.3 Market Breakup by Route of Administration
9.3.6.4 Market Breakup by Disease Indication
9.3.6.5 Market Breakup by Distribution Channel
9.3.6.6 Key Players
9.3.6.7 Market Forecast (2025-2033)
9.3.7 Others
9.3.7.1 Historical and Current Market Trends (2019-2024)
9.3.7.2 Market Forecast (2025-2033)
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Drivers
9.4.1.2 Historical and Current Market Trends (2019-2024)
9.4.1.3 Market Breakup by Route of Administration
9.4.1.4 Market Breakup by Disease Indication
9.4.1.5 Market Breakup by Distribution Channel
9.4.1.6 Key Players
9.4.1.7 Market Forecast (2025-2033)
9.4.2 Mexico
9.4.2.1 Market Drivers
9.4.2.2 Historical and Current Market Trends (2019-2024)
9.4.2.3 Market Breakup by Route of Administration
9.4.2.4 Market Breakup by Disease Indication
9.4.2.5 Market Breakup by Distribution Channel
9.4.2.6 Key Players
9.4.2.7 Market Forecast (2025-2033)
9.4.3 Others
9.4.3.1 Historical and Current Market Trends (2019-2024)
9.4.3.2 Market Forecast (2025-2033)
9.5 Middle East and Africa
9.5.1 Market Drivers
9.5.2 Historical and Current Market Trends (2019-2024)
9.5.3 Market Breakup by Route of Administration
9.5.4 Market Breakup by Disease Indication
9.5.5 Market Breakup by Distribution Channel
9.5.6 Market Breakup by Country
9.5.7 Key Players
9.5.8 Market Forecast (2025-2033)
9.6 Attractive Investment Proposition by Region

10 Global Non-steroidal Anti-inflammatory Drugs Market – Competitive Landscape
10.1 Overview
10.2 Market Structure
10.3 Market Share by Key Players
10.4 Market Player Positioning
10.5 Top Winning Strategies
10.6 Competitive Dashboard
10.7 Company Evaluation Quadrant

11 Profiles of Key Players
11.1 Assertio Therapeutics, Inc.
11.1.1 Business Overview
11.1.2 Services Offered
11.1.3 Business Strategies
11.1.4 Financials
11.1.5 Major News and Events
11.2 AstraZenca
11.2.1 Business Overview
11.2.2 Services Offered
11.2.3 Business Strategies
11.2.4 Financials
11.2.5 SWOT Analysis
11.2.6 Major News and Events
11.3 Bayer AG
11.3.1 Business Overview
11.3.2 Services Offered
11.3.3 Business Strategies
11.3.4 Financials
11.3.5 SWOT Analysis
11.3.6 Major News and Events
11.4 Dr. Reddy's Laboratories Limited
11.4.1 Business Overview
11.4.2 Services Offered
11.4.3 Business Strategies
11.4.4 Financials
11.4.5 SWOT Analysis
11.4.6 Major News and Events
11.5 Eli Lilly and Company
11.5.1 Business Overview
11.5.2 Services Offered
11.5.3 Business Strategies
11.5.4 Financials
11.5.5 SWOT Analysis
11.5.6 Major News and Events
11.6 GSK Plc
11.6.1 Business Overview
11.6.2 Services Offered
11.6.3 Business Strategies
11.6.4 Financials
11.6.5 SWOT Analysis
11.6.4 Major News and Events
11.7 Horizon Therapeutics Public Limited Company
11.7.1 Business Overview
11.7.2 Services Offered
11.7.3 Business Strategies
11.7.4 Financials
11.7.5 SWOT Analysis
11.7.6 Major News and Events
11.8 Johnson & Johnson
11.8.1 Business Overview
11.8.2 Services Offered
11.8.3 Business Strategies
11.8.4 Financials
11.8.5 SWOT Analysis
11.8.6 Major News and Events
11.9 Merck & Co., Inc.
11.9.1 Business Overview
11.9.2 Services Offered
11.9.3 Business Strategies
11.9.4 Financials
11.9.5 SWOT Analysis
11.9.6 Major News and Events
11.10 Pfizer Inc.
11.10.1 Business Overview
11.10.2 Services Offered
11.10.3 Business Strategies
11.10.4 Financials
11.10.5 SWOT Analysis
11.10.6 Major News and Events
11.11 Reckitt Benckiser Group PLC
11.11.1 Business Overview
11.11.2 Services Offered
11.11.3 Business Strategies
11.11.4 Financials
11.11.5 SWOT Analysis
11.11.6 Major News and Events
11.12 Sanofi
11.12.1 Business Overview
11.12.2 Services Offered
11.12.3 Business Strategies
11.12.4 Financials
11.12.5 SWOT Analysis
11.12.6 Major News and Events
11.13 Sun Pharmaceutical Industries Ltd
11.13.1 Business Overview
11.13.2 Services Offered
11.13.3 Business Strategies
11.13.4 Financials
11.13.5 SWOT Analysis
11.13.6 Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

12 Global Non-steroidal anti-inflammatory Drugs Market - Industry Analysis
12.1 Drivers, Restraints, and Opportunities
12.1.1    Overview
12.1.2    Drivers
12.1.3    Restraints
12.1.4    Opportunities
12.1.5    Impact Analysis
12.2 Porters Five Forces Analysis
12.2.1    Overview
12.2.2    Bargaining Power of Buyers
12.2.3    Bargaining Power of Suppliers
12.2.4    Degree of Competition
12.2.5    Threat of New Entrants
12.2.6    Threat of Substitutes
12.3 Value Chain Analysis

13 Strategic Recommendations

14 Appendix

Non-steroidal Anti-inflammatory Drugs Market by Route of Administration (Oral, Parenteral, Topical), Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials